Acorda Therapeutics

Novartis MS Pill Wins European Backing as Rival Acorda Rejected
Bloomberg
Fri, 01/21/11 - 10:11 am
Novartis
MS
multiple sclerosis
Europe
Acorda Therapeutics
Gilenya
Merck KGaA
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:25 pm
Watson Pharmaceuticals
Theratechnologies
Shire
Savient
Sanofi
Roche
Orphan Europe
Novo Nordisk
Novartis
Merz
JNJ
HRA Pharma
Genzyme
Forest Labs
FDA
Eisai
Dainippon Sumitomo
Chemiche Fabrik Kresussler
Boehringer Ingelheim
Bayer
Auxilium
Amgen
Allergan
Acorda Therapeutics
Acorda swings to 3Q profit due to MS drug
Yahoo/AP
Mon, 11/1/10 - 07:55 pm
earnings
Acorda Therapeutics
The 3 Words Every Biotech Investor Wants to Hear
Motley Fool
Thu, 10/28/10 - 11:00 am
biotech
Acorda Therapeutics
Elan
JNJ
Biogen Idec
Acorda Hopes to Meet Huge Need in Challenging Stroke Market
Seeking Alpha
Thu, 10/21/10 - 11:16 am
Acorda Therapeutics
Athersys
These Are the Top 10 Pharma Underperform Calls
Motley Fool
Thu, 08/26/10 - 08:03 pm
Dendreon
Human Genome
Targacept
Vanda
Pharmacyclics
Acorda Therapeutics
MannKind
Biogen Starts Patient Enrollment
Yahoo/Zacks.com
Wed, 05/26/10 - 11:11 am
Biogen Idec
Abbott Laboratories
Acorda Therapeutics
daclizumab
Avonex
MS
Acorda Therapeutics, Inc. Q1 2010 Earnings Call Transcript
Seeking Alpha
Sat, 05/1/10 - 10:31 am
Acorda Therapeutics
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wed, 04/14/10 - 01:56 pm
MS
Acorda Therapeutics
AMPYRA
multiple sclerosis
Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
Tue, 04/13/10 - 10:35 am
Acorda Therapeutics
AMPYRA
Cell Therapeutics
pixantrone
Pixuvri
Dendreon
Provenge
InterMune
Esbriet
Pozen
Vimovo
XenoPort
Horizant
Astellas
OSI Pharmaceuticals
Ironwood
Biotech Calendar: Key Dates for April
TheStreet.com
Mon, 04/5/10 - 09:53 am
Forest Labs
Celgene
Genzyme
Lexicon Pharmaceuticals
Cell Therapeutics
Acadia
Acorda Therapeutics
Vertex Pharmaceuticals
Indenix
Pozen
Acura Pharmaceuticals
OSI Pharmaceuticals
Cyclacel
Peregrine Pharmaceuticals
Anadys
Pharmasset
Dendreon
Acorda applies to extend Ampyra patent protection
Yahoo/AP
Mon, 03/22/10 - 09:54 am
Acorda Therapeutics
patents
AMPYRA
MS
multiple sclerosis
Analyst reiterates 'Market Perform' on Acorda, says value reflects Ampyra launch prospect
Yahoo/AP
Wed, 02/24/10 - 10:11 am
Acorda Therapeutics
AMPYRA
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 11:14 am
FDA
Cadence Pharmaceuticals
Acorda Therapeutics
Auxilium
Gilead Sciences
Shire
Amylin
Cell Therapeutics
Dendreon
InterMune
Amgen
Human Genome
NicOx
Vivus
Arena Pharmaceuticals
Orexigen
4 Winning Biotechs For Your Portfolio: Senior Analyst
CNBC
Mon, 02/8/10 - 12:30 pm
Amgen
Gilead Sciences
Dendreon
Acorda Therapeutics
Acorda's MS Drug May Not Be the Windfall Investors Expect
Seeking Alpha
Wed, 01/27/10 - 10:57 am
Acorda Therapeutics
MS
multiple sclerosis
Biogen Idec
AMPYRA
Acorda: After FDA Approval, What's Next for Ampyra?
Seeking Alpha
Tue, 01/26/10 - 08:55 am
AMPYRA
Acorda Therapeutics
Debunking the Accorda Therapeutics Merger Rumors
BNET Pharma
Mon, 01/25/10 - 12:37 pm
Acorda Therapeutics
M&A
Biogen Idec
Teva Pharmaceuticals
AMPYRA
What the New MS Drug (AMPYRA) Does (and What It Doesn’t Do)
Wall Street Journal
Sat, 01/23/10 - 10:52 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Yahoo/Business Wire
Sat, 01/23/10 - 10:50 am
Acorda Therapeutics
AMPYRA
multiple sclerosis

Pages